SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-17-065093
Filing Date
2017-12-22
Accepted
2017-12-22 16:07:39
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tv481921_424b5.htm 424B5 842006
2 GRAPHIC tv481921_img01.jpg GRAPHIC 11948
3 GRAPHIC tv481921_img02.jpg GRAPHIC 11939
4 GRAPHIC tv481921_img03.jpg GRAPHIC 37549
5 GRAPHIC tv481921_img04.jpg GRAPHIC 193540
  Complete submission text file 0001144204-17-065093.txt   1194720
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-203133 | Film No.: 171272792
SIC: 2834 Pharmaceutical Preparations